Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.

Defective Autophagy in Atherosclerosis: To Die or to Senesce?

Open access
Grootaert, Mandy O. J., Roth, Lynn, Schrijvers, Dorien M., De Meyer, Guido R. Y., Martinet, Wim · 2018 · Oxidative Medicine and Cellular Longevity

Abstract

Autophagy is a subcellular process that plays an important role in the degradation of proteins and damaged organelles such as mitochondria (a process termed “mitophagy”) via lysosomes. It is crucial for regulating protein and mitochondrial quality control and maintaining cellular homeostasis, whereas dysregulation of autophagy has been implicated in a wide range of diseases including atherosclerosis. Recent evidence has shown that the autophagic process becomes dysfunctional during the progression of atherosclerosis, regardless of whether there are many autophagy‐stimulating factors (e.g., reactive oxygen species, oxidized lipids, and cytokines) present within the atherosclerotic plaque. This review highlights the recent insights into the causes and consequences of defective autophagy in atherosclerosis, with a special focus on the role of autophagy and mitophagy in plaque macrophages, vascular smooth muscle cells (VSMCs), and endothelial cells (ECs). It has been shown that defective autophagy can promote apoptosis in macrophages but that it accelerates premature senescence in VSMCs. In the ECs, defective autophagy promotes both apoptosis and senescence. We will discuss the discrepancy between these three cell types in their response to autophagy deficiency and underline the cell type‐dependent role of autophagy, which may have important implications for the efficacy of autophagy‐targeted treatments for atherosclerosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2018/7687083

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Role of autophagy in macrophages, vascular smooth muscle cells, and endothelial cells in atherosclerosis. (a) Oxidized lipids (e.g., oxLDL and 7-ketocholesterol) present in atherosclerotic plaques can stimulate autophagy in macrophages (MΦ) in either a direct manner or indirectly through induction of ER stress. Degradation of damaged proteins and organelles in the autophagosome favors cell survival. Specific removal of dysfunctional mitochondria by mitophagy also limits inflammation. Macrophage autophagy also promotes cholesterol efflux by regulating the delivery of lipid droplets to lysosomes. (b) Autophagy in vascular smooth muscle cells (VSMCs) can be triggered by various atherosclerosis-related stimuli such as oxLDL, 7-ketocholesterol, 4-hydroxynonenal, osteopontin, and TNFα. oxLDL activates mitophagy in VSMCs as a safeguarding mechanism against apoptosis. VSMC autophagy may also be stimulated by the growth factor PDGF that promotes the development of a synthetic, hyperproliferative VSMC phenotype. (c) Autophagy/mitophagy in ECs can be stimulated by different atherogenic stimuli such as oxLDL, AGEs, and saturated fatty acids to promote EC survival. Upon oxLDL exposure, autophagy is activated either directly or indirectly through induction of ER stress and facilitates oxLDL degradation. Also exposure to high shear stress stimulates protective autophagy in ECs. (d) Defective autophagy in macrophages (e.g., by Atg5 deficiency) results in accumulation of damaged proteins and organelles, such as mitochondria, which leads to increased oxidative stress (1) and apoptosis (2). Apoptotic autophagy-deficient macrophages are not properly phagocytized (3). Autophagy-defective macrophages are further characterized by hyperactivation of the inflammasome (4) and impaired cholesterol efflux (5). (e) Defective autophagy in VSMCs (e.g., by Atg7 deficiency) leads to accumulation of p62, resulting in activation of the Nrf2 antioxidative pathway (1) and p16/pRB-mediated cellular senescence (2). Autophagy-deficient VSMCs are characterized by cellular and nuclear hypertrophy (3), increased SAβG activity (4), collagen deposition (5), increased secretion of promigratory factors (TGFβ, MMP9, and SDF1) (6), and decreased proliferation (7). (f) Exposure of ECs to low/disturbed shear stress impairs autophagy. Autophagy deficiency in ECs (e.g., by Atg5 or Atg7 deficiency) promotes apoptosis (1) and senescence (2). Autophagy-deficient ECs are also characterized by defective oxLDL degradation (3) and increased inflammation (4). 4-HNE: 4-hydroxynonenal; 7-KC: 7-ketocholesterol; AP: autophagosome; ER: endoplasmic reticulum; LYS: lysosomes; NU: nucleus; OP: osteopontin; ROS: reactive oxygen species; AGEs: advanced glycation end products.
Figure 1 Role of autophagy in macrophages, vascular smooth muscle cells, and endothelial cells in atherosclerosis. (a) Oxidized lipids (e.g., oxLDL and 7-ketocholesterol) present in atherosclerotic plaques can stimulate autophagy in macrophages (MΦ) in either a direct manner or indirectly through induction of ER stress. Degradation of damaged proteins and organelles in the autophagosome favors cell survival. Specific removal of dysfunctional mitochondria by mitophagy also limits inflammation. Macrophage autophagy also promotes cholesterol efflux by regulating the delivery of lipid droplets to lysosomes. (b) Autophagy in vascular smooth muscle cells (VSMCs) can be triggered by various atherosclerosis-related stimuli such as oxLDL, 7-ketocholesterol, 4-hydroxynonenal, osteopontin, and TNFα. oxLDL activates mitophagy in VSMCs as a safeguarding mechanism against apoptosis. VSMC autophagy may also be stimulated by the growth factor PDGF that promotes the development of a synthetic, hyperproliferative VSMC phenotype. (c) Autophagy/mitophagy in ECs can be stimulated by different atherogenic stimuli such as oxLDL, AGEs, and saturated fatty acids to promote EC survival. Upon oxLDL exposure, autophagy is activated either directly or indirectly through induction of ER stress and facilitates oxLDL degradation. Also exposure to high shear stress stimulates protective autophagy in ECs. (d) Defective autophagy in macrophages (e.g., by Atg5 deficiency) results in accumulation of damaged proteins and organelles, such as mitochondria, which leads to increased oxidative stress (1) and apoptosis (2). Apoptotic autophagy-deficient macrophages are not properly phagocytized (3). Autophagy-defective macrophages are further characterized by hyperactivation of the inflammasome (4) and impaired cholesterol efflux (5). (e) Defective autophagy in VSMCs (e.g., by Atg7 deficiency) leads to accumulation of p62, resulting in activation of the Nrf2 antioxidative pathway (1) and p16/pRB-mediated cellular senescence (2). Autophagy-deficient VSMCs are characterized by cellular and nuclear hypertrophy (3), increased SAβG activity (4), collagen deposition (5), increased secretion of promigratory factors (TGFβ, MMP9, and SDF1) (6), and decreased proliferation (7). (f) Exposure of ECs to low/disturbed shear stress impairs autophagy. Autophagy deficiency in ECs (e.g., by Atg5 or Atg7 deficiency) promotes apoptosis (1) and senescence (2). Autophagy-deficient ECs are also characterized by defective oxLDL degradation (3) and increased inflammation (4). 4-HNE: 4-hydroxynonenal; 7-KC: 7-ketocholesterol; AP: autophagosome; ER: endoplasmic reticulum; LYS: lysosomes; NU: nucleus; OP: osteopontin; ROS: reactive oxygen species; AGEs: advanced glycation end products.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 125 references

Research works printed but not linked: 1

  1. Grootaert M. O. J., 2016, Autophagy, 251

Cited by

See all 147

Metadata

Authors
Grootaert, M. O. J., Roth, L., Schrijvers, D. M., De Meyer, G. R. Y., & Martinet, W.
Affiliations
  • University of Antwerp (BE)
  • HistoGeneX (Belgium) (BE)
Corresponding author
Grootaert, Mandy O. J.
Venue
Oxidative Medicine and Cellular Longevity
Publisher
Wiley
Published
2018-01
Volume
2018
Issue
1
Pages
7687083-7687083
ISSN
  • 1942-0994 (ISSN-L)
  • 1942-0900
OpenAlex
W2790064807
Cited by
147
References
125
Citations by year
2026: 6 · 2025: 12 · 2024: 13 · 2023: 19 · 2022: 23 · 2021: 32 · 2020: 22 · 2019: 18 · 2018: 2
FWCI
2.65
Type
journal article
Language
en
Open access
Locations
  • Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Lirias (KU Leuven) (submittedVersion, cc-by)
  • Digital Access to Libraries (submittedVersion, other-oa)
Funders
  • Universiteit Antwerpen
  • Fonds Wetenschappelijk Onderzoek (G.0412.16N)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
Keywords
atherosclerosis, mitophagy, premature senescence, apoptosis, vascular smooth muscle cells, endothelial cells, reactive oxygen species, oxidized lipids, cell type-dependent response, autophagy-targeted therapy
MeSH terms
Animals, Autophagy, Humans, Cellular Senescence, Apoptosis, Atherosclerosis, Mitophagy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Defective Autophagy in Atherosclerosis: To Die or to Senesce? https://app.cochat.ai/papers/10.1155/2018/7687083
The paper
Grootaert, M. O. J., Roth, L., Schrijvers, D. M., De Meyer, G. R. Y., & Martinet, W. (2018). Defective Autophagy in Atherosclerosis: To Die or to Senesce? Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2018/7687083

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.